CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine‐based regimens for a median of 9 years

Authors :: Podzamczer, D
Tiraboschi, Jm
Mallolas, J
Cárdenes, Ma
Casas, E
Castro, A
Echevarria, S
Leal, M
De Quirós, Jc Lopez Bernanldo
Moreno, S
Puig, T
Ribera, E
Villalonga, C
Sirvent, Jl Gomez
Heranejos, Ja Garcia
Lopez?Aldeguer, J
Barrufet, P
Force, L
Santos, I
Sanz, J
Source :: Journal of the International AIDS Society. November, 2010, Vol. 13, p81, 2 p.
Publication Year :: 2010
Abstract: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK<br />Purpose of the study To evaluate long‐term outcomes in pts maintaining a NVP‐based regimen Methods Retrospective cohort study. Pts received a NVP regimen for at least 5 years and continued [...]

Subjects :: CD4 lymphocytes -- Health aspects -- Measurement
Blood lipids -- Health aspects -- Measurement
Hepatitis C -- Drug therapy -- Patient outcomes
Nevirapine -- Patient outcomes
HIV infection -- Drug therapy -- Patient outcomes
Health

Full Text Access

Tools